<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Targeted Metabolomics to Understand the Association between Arsenic Metabolism and Diabetes-Related Outcomes: Preliminary Evidence from the Strong Heart Family Study</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2020-01-01">2020 January 01.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Miranda</forename><forename type="middle">J</forename><surname>Spratlen</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Environmental Health Sciences</orgName>
								<orgName type="institution">Columbia University Mailman School of Public Health</orgName>
								<address>
									<settlement>New York</settlement>
									<region>New York</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Environmental Health &amp; Engineering</orgName>
								<orgName type="institution">Johns Hopkins Bloomberg School of Public Health</orgName>
								<address>
									<settlement>Baltimore</settlement>
									<region>Maryland</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maria</forename><surname>Grau-Perez</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Environmental Health Sciences</orgName>
								<orgName type="institution">Columbia University Mailman School of Public Health</orgName>
								<address>
									<settlement>New York</settlement>
									<region>New York</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">Fundación Investigación Clínico de Valencia-INCLIVA</orgName>
								<orgName type="institution" key="instit2">Area of Cardiometabolic and Renal Risk</orgName>
								<address>
									<settlement>Valencia, Valencia</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Statistics and Operational Research</orgName>
								<orgName type="institution">University of Valencia</orgName>
								<address>
									<settlement>Valencia, Valencia</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jason</forename><forename type="middle">G</forename><surname>Umans</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">MedStar Health Research Institute</orgName>
								<address>
									<settlement>Hyattsville</settlement>
									<region>Maryland</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Georgetown University School of Medicine</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Joseph</forename><surname>Yracheta</surname></persName>
							<affiliation key="aff6">
								<orgName type="institution">Missouri Breaks Industries Research, Inc</orgName>
								<address>
									<settlement>Eagle Butte</settlement>
									<region>South Dakota</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lyle</forename><forename type="middle">G</forename><surname>Best</surname></persName>
							<affiliation key="aff6">
								<orgName type="institution">Missouri Breaks Industries Research, Inc</orgName>
								<address>
									<settlement>Eagle Butte</settlement>
									<region>South Dakota</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kevin</forename><surname>Francesconi</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Institute of Chemistry -Analytical Chemistry</orgName>
								<orgName type="institution">University of Graz</orgName>
								<address>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Walter</forename><surname>Goessler</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Institute of Chemistry -Analytical Chemistry</orgName>
								<orgName type="institution">University of Graz</orgName>
								<address>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Teodoro</forename><surname>Bottiglieri</surname></persName>
							<affiliation key="aff8">
								<orgName type="institution">Baylor Scott &amp; White Research Institute</orgName>
								<address>
									<settlement>Dallas</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mary</forename><forename type="middle">V</forename><surname>Gamble</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Environmental Health Sciences</orgName>
								<orgName type="institution">Columbia University Mailman School of Public Health</orgName>
								<address>
									<settlement>New York</settlement>
									<region>New York</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Shelley</forename><forename type="middle">A</forename><surname>Cole</surname></persName>
							<affiliation key="aff9">
								<orgName type="institution">Texas Biomedical Research Institute</orgName>
								<address>
									<addrLine>San Antonio</addrLine>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jinying</forename><surname>Zhao</surname></persName>
							<affiliation key="aff10">
								<orgName type="department">College of Public Health and Health Professions and the College of Medicine</orgName>
								<orgName type="institution">University of Florida</orgName>
								<address>
									<settlement>Gainesville</settlement>
									<region>Florida</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ana</forename><surname>Navas-Acien</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Environmental Health Sciences</orgName>
								<orgName type="institution">Columbia University Mailman School of Public Health</orgName>
								<address>
									<settlement>New York</settlement>
									<region>New York</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Environmental Health &amp; Engineering</orgName>
								<orgName type="institution">Johns Hopkins Bloomberg School of Public Health</orgName>
								<address>
									<settlement>Baltimore</settlement>
									<region>Maryland</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="department">Department of Environmental Health Sciences</orgName>
								<orgName type="institution">Columbia University</orgName>
								<address>
									<addrLine>122 W168th</addrLine>
									<postCode>1105, 10032</postCode>
									<settlement>Room, New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Targeted Metabolomics to Understand the Association between Arsenic Metabolism and Diabetes-Related Outcomes: Preliminary Evidence from the Strong Heart Family Study</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2020-01-01">2020 January 01.</date>
						</imprint>
					</monogr>
					<idno type="MD5">CA0B4FEDDFB113601935165D119F1FAE</idno>
					<idno type="DOI">10.1016/j.envres.2018.09.034</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:51+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Metabolomics</term>
					<term>diabetes</term>
					<term>arsenic metabolism</term>
					<term>one carbon metabolism</term>
					<term>American Indians</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Inorganic arsenic exposure is ubiquitous and both exposure and inter-individual differences in its metabolism have been associated with cardiometabolic risk.</s><s>A more efficient arsenic metabolism profile (lower MMA%, higher DMA%) has been associated with reduced risk for arsenic-related health outcomes.</s><s>This profile, however, has also been associated with increased risk for diabetes-related outcomes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Objectives:</head><p><s>The mechanism behind these conflicting associations is unclear; we hypothesized the one-carbon metabolism (OCM) pathway may play a role.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods:</head><p><s>We evaluated the influence of OCM on the relationship between arsenic metabolism and diabetes-related outcomes (HOMA2-IR, waist circumference, fasting plasma glucose) using metabolomic data from an OCM-specific and P180 metabolite panel measured in plasma, arsenic metabolism measured in urine, and HOMA2-IR and FPG measured in fasting plasma.</s><s>Samples were drawn from baseline visits (2001-2003) in 59 participants from the Strong Heart Family Study, a family-based cohort study of American Indians aged ≥14 years from Arizona, Oklahoma, and North/South Dakota.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results:</head><p><s>In unadjusted analyses, a 5% increase in DMA% was associated with higher HOMA2-IR (geometric mean ratio (GMR)= 1.13 (95% CI: 1.03, 1.25)) and waist circumference (mean  difference=3.66</s><s>(0.95, 6.38).</s><s>MMA% was significantly associated with lower HOMA2-IR and waist circumference.</s><s>After adjustment for OCM-related metabolites (SAM, SAH, cysteine, glutamate, lysophosphatidylcholine 18.2, and three phosphatidlycholines), associations were attenuated and no longer significant.</s></p><p><s>Conclusions: These preliminary results indicate that the association of lower MMA% and higher DMA% with diabetes-related outcomes may be influenced by OCM status, either through confounding, reverse causality, or mediation.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">INTRODUCTION</head><p><s><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref> Inter-individual differences in methylation capacity have been associated with risk for subsequent health outcomes.</s><s>Several studies have reported higher percentages of MMA (MMA%) and lower percentages of DMA (DMA%) in the urine to be associated with greater risk for many arsenic-induced health effects including skin lesions <ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b16">[16]</ref> , cancers of the skin, bladder, lung <ref type="bibr" target="#b17">[17]</ref><ref type="bibr" target="#b18">[18]</ref><ref type="bibr" target="#b19">[19]</ref><ref type="bibr" target="#b20">[20]</ref><ref type="bibr" target="#b21">[21]</ref><ref type="bibr" target="#b22">[22]</ref> and cardiovascular disease, <ref type="bibr" target="#b23">[23]</ref><ref type="bibr" target="#b24">[24]</ref><ref type="bibr" target="#b25">[25]</ref> even after controlling for arsenic exposure levels.</s><s>However, for metabolic-related health outcomes, including diabetes and metabolic syndrome, higher MMA% and lower DMA% is associated with a lower risk.</s><s>3, 26-28 The reasons for the contrasting association between arsenic metabolism and metabolic outcomes versus other arsenic-associated health outcomes are not clear.</s><s><ref type="bibr" target="#b38">[38]</ref><ref type="bibr" target="#b39">[39]</ref><ref type="bibr" target="#b40">[40]</ref><ref type="bibr" target="#b41">[41]</ref><ref type="bibr" target="#b42">[42]</ref> OCM, a biochemical pathway that is dependent on folate, facilitates the generation of Sadenosylmethionine (SAM), a central metabolite, which serves as the methyl donor for numerous methylation reactions including the methylation of arsenic. <ref type="bibr" target="#b43">43</ref></s><s> this study, we explored potential mechanistic pathways that may explain the associations between arsenic metabolism and metabolic outcomes through the targeted evaluation of specific metabolites.</s><s>The association between arsenic metabolism and metabolic profiles has been relatively unexplored.</s><s>5]<ref type="bibr" target="#b46">[46]</ref><ref type="bibr" target="#b47">[47]</ref><ref type="bibr" target="#b48">[48]</ref> Our analyses expanded on these findings by evaluating associations between OCM-and diabetes-associated metabolites, arsenic metabolism biomarkers, and diabetes-related outcomes including waist circumference, fasting plasma glucose and HOMA2-IR.</s><s>Our selection of these outcomes was informed by previous work conducted in our study population that have reported associations between arsenic metabolism and diabetes <ref type="bibr" target="#b2">3</ref> , a homeostasis model assessment index (HOMA2-IR), <ref type="bibr" target="#b49">49</ref> body mass index (BMI) <ref type="bibr" target="#b50">50</ref> , waist circumference <ref type="bibr" target="#b51">51</ref> and metabolic syndrome <ref type="bibr" target="#b51">51</ref> ; all of these outcomes are linked to insulin resistance.</s><s>Previous evaluation of the association between arsenic metabolism and other metabolic outcomes in this study population, including triglycerides and high density lipoprotein cholesterol, yielded null results and were therefore not evaluated in this analysis.</s></p><p><s>Using data from the Strong Heart Family Study (SHFS), a family-based cohort study comprised of American Indian tribal members aged 14 years and older from Arizona, Oklahoma, and North and South Dakota, we conducted a pilot study including 59 participants.</s><s>We analyzed nine OCM-specific metabolites in addition to the Biocrates P180 metabolite panel (188 endogenous metabolites including amino acids, lipids, and carbohydrates, many of them related to OCM) in baseline plasma samples collected in 2001-2003.</s><s>47]<ref type="bibr" target="#b48">[48]</ref><ref type="bibr" target="#b52">[52]</ref><ref type="bibr" target="#b53">[53]</ref><ref type="bibr" target="#b54">[54]</ref><ref type="bibr" target="#b55">[55]</ref><ref type="bibr" target="#b56">[56]</ref><ref type="bibr" target="#b57">[57]</ref> Given the small sample size, our analyses are considered exploratory and aim to describe the relationship of OCM-specific metabolites and previously identified incident diabetes-associated metabolites with arsenic metabolism and metabolic outcomes including fasting glucose levels, insulin resistance and waist circumference.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1">Study population</head><p><s>The SHFS recruited a total of 3,838 participants for baseline visits in 1998-1999 and 2001-2003 from three centers: Arizona, Oklahoma and North/South Dakota.</s><s>The age range of the participants in the SHFS was 14 to 93 (mean 42) years.</s><s>At each visit, in-person interviews, physical examinations and biological specimens were obtained.</s><s>Methods have been described in detail previously. <ref type="bibr" target="#b58">58</ref></s><s>For this pilot study, we randomly selected 20 participants per study region among those with a baseline visit in 2001-2003 and with complete data on the following variables: urinary arsenic and creatinine, education, smoking status, body mass index (BMI), estimated glomerular filtration rate (eGFR), alcohol intake, dietary intake information and telomeres.</s><s>One participant was excluded because of a missing sample, leaving 59 participants in the pilot evaluation of plasma metabolites.</s><s>All participants provided informed consent before participation and study protocols were approved by multiple institutional review boards, participating communities and The Indian Health Service.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">Data Collection</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.1">Urinary</head><p><s>Arsenic-Morning spot urine samples were collected in polypropylene tubes, frozen within 1 to 2 hours of collection, shipped buried in dry ice and stored at −70°C in the Penn Medical Laboratory, MedStar Research Institute, Washington, DC for up to 18 years.</s><s>The freezers have been operating under a strict quality control system to guarantee secure sample storage.</s><s>For arsenic analyses, urine samples were thawed and up to 1.0 mL from each urine sample was transferred to a small vial, transported on dry ice to the Trace Element Laboratory at Graz University, Austria and stored at −80°C until analyses.</s><s>The urine concentrations of arsenite, arsenate, MMA and DMA were measured using high performance liquid chromatography/inductively coupled plasma mass spectrometry (HPLC/ ICPMS).</s><s>The limits of detection were 0.1 μg/L for arsenite, arsenate, MMA and DMA.</s><s>The inter-assay coefficients of variation for arsenite, arsenate, MMA, DMA and total arsenic were 14.7%, 6.9%, 6.4%, 6.0% and 4.7% respectively.</s><s>For participants with concentrations below the limit of detection (less than 5% for all species) for total arsenic or for the arsenic species we imputed the corresponding limit of detection divided by the square root of two.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.2">Outcome</head><p><s>Measurements-Participants were asked to fast for 12 hours before blood sample collection.</s><s>Biological specimen aliquots were stored at −70°C at the Texas Biomedical Research Institute (Texas Biomed) in San Antonio, TX.</s><s>Most baseline laboratory determinations have been performed at the MedStar Health Research Institute, Washington DC under strict quality control procedures including enzymatic methods for fasting plasma creatinine and glucose and radioimmunoassay for fasting insulin.</s><s>HOMA2-IR was used as a surrogate measure of insulin resistance and was calculated with the computed solved model for HOMA2-IR <ref type="bibr" target="#b59">59</ref> using fasting glucose and insulin values. <ref type="bibr" target="#b60">60,</ref><ref type="bibr" target="#b61">61</ref> </s><s>ist circumference was measured by centrally trained nurses following a standardized protocol at the same visit of spot urine and fasting blood sample collection. <ref type="bibr" target="#b58">58</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.3">OCM Metabolomics and P180</head><p><s>Panel-Plasma samples were used to measure OCM nutrients and nutrient intermediates.</s><s>Some OCM intermediates can be affected by freeze-thaw cycles and were measured in samples that had never been thawed before.</s><s>Targeted OCM metabolomic analysis of plasma was by liquid chromatography tandem mass spectrometery (LC-MS/MS) at the Center of Metabolomics, Baylor Research Institute under the direction of Dr. Teodoro Bottiglieri.</s><s>3]<ref type="bibr" target="#b64">[64]</ref> This metabolic panel provides a quantitative comprehensive assessment of OCM.</s><s>Each plasma sample (&lt;300 μL) was processed by addition of labeled-isotope internal standards followed by deproteinization.</s><s>Processed extracts of samples were transferred to a 96 well microtiter plate for analysis.</s><s>3]<ref type="bibr" target="#b64">[64]</ref> Sample injection and separation was performed by a Shimadzu Nexera UPLC System interfaced with a 5500QTRAP® (Sciex).</s><s>All data were collected and analyzed using Analyst software version 1.5.2.</s><s>Stable isotopes were used for each metabolite to account for matrix effects related ion-suppression, and the quantitative values obtained were expressed as μmol/L.</s><s>Quality control samples (2 levels) were positioned at the start, in the middle and at the end of each batch of samples analyzed.</s><s>The inter assay coefficients of variability for all metabolites were &lt;20%, with most &lt;15%.</s></p><p><s>The P180 Panel (Biocrates Life Sceinces, Innsbruck, Austria) covers carefully selected metabolic pathways which includes 188 metabolites from 6 compound classes including hexoses, amino acids, biogenic amines, acylcarnitines, glycerophospholipids and sphingolipids.</s><s>For a more targeted analysis, we selected metabolites that have been previously associated with incident diabetes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.4">Other</head><p><s>Variables-A standardized questionnaire was conducted during the inperson interviews and included sociodemographic data (age, sex), smoking history, alcohol use, and medical history. <ref type="bibr" target="#b65">65</ref></s><s>Physical exam measures (waist circumference, height and weight) were performed by centrally trained nurses following a standardized protocol; this visit included collection of spot urine and fasting blood samples. <ref type="bibr" target="#b58">58</ref></s><s>Estimated daily averages of dietary intake of OCM related micronutrients, including vitamins B 2 , B 6 and folate, as well as supplement data, were measured during the baseline visit through an intervieweradministered Block 119-item food frequency questionnaire (FFQ).</s><s>The Block questionnaire is one of the most widely used questionnaires with demonstrated reliability and validity. <ref type="bibr" target="#b67">66</ref></s><s>o enhance accuracy of the questionnaire in this cohort, additional questions relating to foods commonly consumed by American Indians were included. <ref type="bibr" target="#b67">66</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">Statistical Analysis</head><p><s>Arsenic exposure was estimated as the sum of inorganic (arsenite, arsenate) and methylated (MMA and DMA) arsenic species adjusted by urine creatinine to correct for urine dilution (∑As).</s><s>∑As was log-transformed to better approximate a normal distribution.</s><s>Arsenic metabolism was estimated as percentages of inorganic arsenic, MMA and DMA, (iAs%, MMA%, DMA%) by dividing the corresponding concentration for each species by the sum of the inorganic and methylated species. <ref type="bibr" target="#b68">67,</ref><ref type="bibr" target="#b69">68</ref> </s><s>rsenic species percentages were modeled in their original scale.</s><s>Arsenic, metabolites and outcome related variables were coded into related groups in the analyses: 1) Arsenic exposure and metabolism biomarkers (∑As, iAs%, MMA% and DMA %); 2) OCM-specific metabolites (Hcys, cysteine, methionine, betaine, choline, SAM, SAH, SAM/SAH, cystathionine and 5-MTHF); 3) Amino-acids (glutamine, glutamate, glycine, histidine, isoleucine, leucine, phenylalanine, serine, tryptophan, tyrosine, valine); 4) Acylcarnitines (propionylcarnitine); 5) Glycerophospholipids (lysophosphatidylcholine (LPC) a C16:0, LPC 18.2, phosphatidylcholine (PC) aa 32:1, PC aa 36:1, PC aa 38:3, PC aa 40:5, PC ae 34:3, PC ae 40:6, PC ae 44:4 and PC ae 44:5); 6) Sphingolipids (sphingomyelin (SM) C16:1); 7) Diabetes related outcomes (fasting plasma glucose (FPG), HOMA2-IR and waist circumference).</s></p><p><s>First, we computed Spearman correlations for metabolites, biomarkers and outcomes within and between the seven group types listed in the previous paragraph and displayed those correlations graphically in correlation globes (Figure <ref type="figure" target="#fig_1">1</ref>).</s><s>Correlations greater than |0.15| were represented by colored lines between the two metabolites and were displayed as solid colored lines for correlations with p-values &lt; 0.05 and as transparent colored lines for pvalues ≥ 0.05.</s><s>Metabolites with correlation p-values &lt; 0.05 between both an arsenic metabolism biomarker (iAs%, MMA%, DMA%) and a metabolic outcome (HOMA2-IR, FPG, waist circumference) were considered "metabolites of interest" and evaluated further.</s><s>P-values were not corrected for multiple comparisons due to the limited sample size.</s><s>Correlations between metabolites of interest and both arsenic metabolism biomarkers and diabetes-related outcomes were also graphically and numerically displayed through a correlation and scatterplot matrix (Figure <ref type="figure">2</ref>).</s><s>Linear regression analyses were conducted to evaluate the associations of diabetes-related outcomes, including HOMA2-IR, FPG and waist circumference, separately, with each metabolite of interest as well as with the arsenic metabolism biomarkers iAs%, MMA% and DMA%.</s><s>HOMA2-IR was log-transformed in analyses to better approximate a normal distribution.</s><s>FPG and waist circumference were normally distributed and therefore included in analyses in their original scale.</s><s>Metabolites of interest were also normally distributed, however, they were standardized (N,0) to reduce variability.</s><s>Results are presented as the geometric mean ratios (GMR) for HOMA2-IR, and mean differences for waist circumference and FPG, comparing the 75 th to 25 th percentile (IQR increase) of each metabolite of interest or 5% increase in arsenic metabolism biomarker.</s><s>Crude models report unadjusted associations and adjusted models report associations fully adjusted for all other metabolites.</s><s>Variance inflation factors (VIF) were used to evaluate multicollinearity in adjusted models which included all OCM metabolites.</s><s>Finally, we constructed directed acyclic graphs (DAGs) of possible pathways between arsenic metabolism, one carbon metabolism and diabetes-related outcomes based on our findings (Figure <ref type="figure">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">RESULTS</head><p><s>The median age of the study population was 35 years with slightly more females (53%) than males (Table <ref type="table" target="#tab_1">1</ref>).</s><s>Most participants were overweight or obese (76%) and met or exceeded the recommended daily allowance (RDA) for intake of vitamins B 2 <ref type="bibr" target="#b70">69</ref> and B 6 70 despite most participants not taking supplements of either vitamin (78%).</s><s>The majority of participants were below the RDA for of folate intake <ref type="bibr" target="#b71">70</ref>  In unadjusted regression analyses evaluating HOMA2-IR as the outcome, a 5% increase of MMA% was associated with a GMR of 0.75 (95% CI: 0.63, 0.89) (Table <ref type="table">2</ref>).</s><s>After adjustment for all eight metabolites (SAM, SAH, cysteine, glutamate, LPC 18.2, PC ae 34:3, PC ae 40:6 and PC aa 38:3), higher MMA% remained associated with reduced HOMA2-IR although the association was markedly attenuated and no longer significant (0.90 (0.74, 1.09)).</s><s>For DMA%, the positive association with HOMA2-IR (GMR 1.13, 95% CI: 1.03, 1.25) became entirely null (GMR 0.99, 95%CI 0.89, 1.11) after adjustment for the other metabolites.</s><s>Six of the eight metabolites were also significantly associated with HOMA2-IR in unadjusted models (increased risk for SAM, SAH, glutamate and PC aa 38:3; decreased risk for LPC 18:2 and PC ae 40:6).</s><s>After adjustment for other metabolites, associations were attenuated and no longer significant except for PC aa 38:3 which remained borderline significantly associated with increased HOMA2-IR.</s><s>iAs% was not significantly associated with HOMA2-IR or any other diabetes-associated outcome (data not shown).</s></p><p><s>Similarly, in unadjusted analyses for waist circumference, an inverse association was observed with a 5% increase in MMA% (−7.83, 95% CI: −12.8, −2.90, cm) and a positive association was observed with a 5% increase in DMA% (3.66, 95% CI: 0.95, 6.38, cm) (Table <ref type="table">2</ref>).</s><s>After adjustment for the other metabolites, the association with MMA% was attenuated to the null (0.93, 95% CI: −4.04, 5.90, cm) and the association with DMA% even reversed direction (−1.16, 95% CI: −3.99, 1.67, cm).</s><s>Several other metabolites were also significantly associated with waist circumference in unadjusted models in the same direction as the associations seen between these metabolites and HOMA2-IR.</s><s>After adjustment for the other metabolites, glutamate remained significantly associated with increased waist circumference and both LPC 18:2 and PC ae 40:6 remained significantly associated with reduced waist circumference.</s><s>The direction of associations between MMA%, DMA% and OCM metabolites with FPG was the same as for the other diabetes-related outcomes, however none of the associations were significant.</s><s>Variance inflation factor (VIF) values were below 4 for all variables in fully OCM-adjusted models, and therefore, multicollinearity was not considered a significant concern.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">DISCUSSION</head><p><s>In this pilot study of 59 men and women from the SHFS, we observed significant correlations between eight metabolites (SAM, SAH, cysteine, glutamate, LPC 18:2, PC ae 34:3, PC ae 40:6 and PC aa 38:3) and both a metabolic outcome (HOMA2-IR, FPG, waist circumference) and at least one arsenic metabolism biomarker (iAs%, MMA% or DMA%).</s><s>Before adjustment, higher MMA% was associated with lower HOMA2-IR and waist circumference, and higher DMA% was associated with higher HOMA2-IR and waist circumference.</s><s>After adjustment for these eight "metabolites of interest", associations between arsenic metabolism and diabetes-related outcomes were substantially attenuated and no longer significant.</s><s>For the metabolites of interest, glutamate, LPC 18:2 and PC ae 40:6 remained statistically significantly associated with waist circumference even after adjustment for other metabolites and for arsenic metabolism biomarkers.</s><s>Together, our results suggest that these metabolites play a key role in the relationship between arsenic metabolism and diabetes-related outcomes and may explain the difference in association seen between arsenic metabolism and diabetes-related outcomes compared to the associations reported for arsenic metabolism and other health outcomes.</s></p><p><s>]<ref type="bibr" target="#b78">[77]</ref> These findings, as well as the shorter half-life and rapid excretion in the urine of DMA compared to iAs, has led to the characterization of higher DMA% and lower iAs% and MMA% in urine as a more efficient arsenic metabolism profile. <ref type="bibr" target="#b79">78</ref></s><s>]<ref type="bibr" target="#b92">[91]</ref> However, in contrast to other arsenic-associated health outcomes, a more efficient arsenic metabolism profile (i.e., higher DMA% but lower iAs% and MMA%) has been associated with increased risk for diabetes <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b78">77</ref> and other diabetes-related outcomes including higher BMI, <ref type="bibr" target="#b50">50</ref> insulin resistance <ref type="bibr" target="#b93">92</ref> , elevated waist circumference <ref type="bibr" target="#b51">51</ref> and metabolic syndrome. <ref type="bibr" target="#b94">93</ref></s><s>The mechanism behind the reported contrasting associations is unclear.</s><s>Some studies have suggested the association between higher DMA% and increased risk for metabolic-related outcomes may be due to DMA III , as trivalent methylated arsenicals are considered the most toxic metabolites; this intermediate is difficult to measure analytically as it rapidly oxidizes to DMA V . <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b27">27,</ref><ref type="bibr" target="#b28">28</ref> O</s><s>her studies have considered confounding by diet, particularly greater intake of OCM nutrients. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b26">26</ref> </s><s>ll eight of the metabolites of interest in our study that were related both to arsenic metabolism and to a metabolic outcome are connected to the OCM pathway, as outlined below (study metabolites underlined) and in Figure <ref type="figure" target="#fig_3">4</ref>, and provide a potentially relevant mechanism behind the association between arsenic metabolism and diabetes-related outcomes.</s></p><p><s>OCM facilitates the generation of SAM, the methyl donor for numerous substrates, which are essential to many biological processes including cellular signaling, DNA methylation, the synthesis of proteins, lipids, hormones and carbohydrates, and arsenic metabolism. <ref type="bibr" target="#b43">43</ref></s><s>AH is a product of SAM-dependent methylation reactions, and is hydrolyzed to Hcys, which can be remethylated to form methionine and activated to regenerate SAM. <ref type="bibr" target="#b43">43</ref></s><s>SAH is a potent inhibitor of most transmethylation reactions, including arsenic, through its binding with methyltransferases. <ref type="bibr" target="#b41">41</ref></s><s>SAH is removed from methyltransferases when Hcys is pulled forward for the remethylation of Hcys to form methionine or diverted to the transsulfuration pathway for glutathione synthesis.</s><s>Glutathione is a tripeptide consisting of cysteine, glutamate, and glycine and is critical to the body's antioxidant response (in its reduced form as GSH), including detoxification of heavy metals. <ref type="bibr" target="#b95">94</ref></s><s>OCM is dependent on essential nutrients -including folate, vitamin B12, vitamin B6, vitamin B2 and choline -for the recruitment and transfer of methyl groups. <ref type="bibr" target="#b8">9</ref></s><s>Indeed, in our study we observed greater SAM in participants with sufficient folate intake versus those with low intake.</s><s>Choline can provide methyl groups for the remethylation of Hcys through conversion to betaine.</s><s>Choline is also used in the synthesis of phosphatidylcholine (PC), an abundant phospholipid involved in maintenance of hepatic lipid metabolism. <ref type="bibr" target="#b96">95</ref></s><s>Four of the eight OCM-related metabolites included in this analysis were PCs, which may also be synthesized through the methylation of phosphatidylethanolamine using SAM as the methyl donor. <ref type="bibr" target="#b97">96</ref></s><s>aaPCs consist of glycerol linked to phosphocholine and two fatty acid residues, and removal of one fatty acid produces LPCs.</s><s>aePC's comprise an ether linkage to one alkyl chain and one polyunsaturated fatty acid. <ref type="bibr" target="#b48">48</ref></s><s>e positive associations that we observed in our study between glutamate and both HOMA2-IR and waist circumference, before and after adjustment for other OCM metabolites and arsenic metabolism, are consistent with several previous prospective and cross-sectional studies, reporting a positive relationship between glutamate and diabetes, <ref type="bibr" target="#b98">[97]</ref><ref type="bibr" target="#b99">[98]</ref><ref type="bibr" target="#b100">[99]</ref><ref type="bibr" target="#b101">[100]</ref><ref type="bibr" target="#b102">[101]</ref> including prospective metabolomic analyses. <ref type="bibr" target="#b54">54,</ref><ref type="bibr" target="#b56">56,</ref><ref type="bibr" target="#b103">102</ref> F</s><s>rther, elevated cerebral glutamate measured via proton magnetic resonance spectroscopy in occipitoparietal grey matter has been reported in adults with metabolic syndrome. <ref type="bibr" target="#b104">103</ref></s><s>In vitro studies in human islet cells have shown chronic exposure to glutamate through treated cell media causes dosedependent increases in insulin secretion as well as β-cell apoptosis. <ref type="bibr" target="#b105">104</ref></s><s>The mechanism behind these associations is likely due to glutamate's role in a regulatory system in which dietary protein ingestion stimulates ß-cells to stimulate insulin secretion: The increase in branched-chain amino acids following a protein-containing meal activates glutamate dehydrogenase in ß-cells which oxidizes glutamate to α-ketoglutarate and there is a consequent increase in the ATP/ADP ratio. <ref type="bibr" target="#b106">105</ref></s><s>Insulin secretion is very sensitive to this because it closes the ATP-gated K+ channel which depolarizes the cell and activates a voltage-gated Ca2+ channel. <ref type="bibr" target="#b106">105</ref></s><s>The increase in Ca2+ then triggers insulin release. <ref type="bibr" target="#b106">105</ref></s><s>urther, excess extracellular levels of glutamate have been shown to inhibit the glutamate/ cysteine antiporter system, which depletes the cells of cysteine, in turn limiting the production of glutathione, thus decreasing the antioxidant defense. <ref type="bibr" target="#b105">104,</ref><ref type="bibr" target="#b107">106</ref> </s><s>, SAH and cysteine were also significantly associated with increases in HOMA2-IR and waist circumference before adjustment for the other OCM metabolites and arsenic metabolism.</s><s>Research on these metabolites and diabetes outcomes is limited, with some evidence suggesting the association may be due to reverse causality.</s><s>An in vitro study found that when hepatic cells were exposed to elevated insulin and glucose, SAM concentrations increased. <ref type="bibr" target="#b108">107</ref></s><s>In addition, animal models have shown insulin resistance and diabetes can alter one carbon metabolism-related metabolites and enzymes, including increases in hepatic SAM, and that administration of insulin can prevent these perturbations. <ref type="bibr" target="#b109">108,</ref><ref type="bibr" target="#b110">109</ref> </s><s>, SAH, glutamate and cysteine all correlated positively with a more efficient arsenic metabolism profile characterized by higher DMA%.</s><s>This is consistent with observational studies from Bangladesh which reported greater SAM to be associated with lower iAs% <ref type="bibr" target="#b111">110</ref> and greater cysteine to be associated with lower MMA% and higher DMA%, <ref type="bibr" target="#b112">111</ref> as well as indirect evidence provided by experimental studies reporting a protective effect of SAM in regard to arsenic toxicity. <ref type="bibr" target="#b113">112,</ref><ref type="bibr" target="#b114">113</ref> </s><s>e found one study that has evaluated the association between glutamate and arsenic metabolism. <ref type="bibr" target="#b115">114</ref></s><s>In contrast to our findings, this study reported glutamate having an inverse correlation with DMA%, however, the study was conducted in pregnant women which may have influenced results.</s><s>Further, both glutamate and cysteine are critical for glutathione synthesis, and increases in glutathione when glutathione levels are low have been shown to accelerate arsenic metabolism, supporting our findings. <ref type="bibr" target="#b116">115</ref></s><s>]<ref type="bibr" target="#b119">[118]</ref> The mechanisms behind the contrasting associations between ae PCs and LPCs versus aa PCs are not clear and warrant further investigation.</s><s>Further, some evidence suggests the association between PCs and diabetes is due to reverse causality.</s><s>Animal studies have shown significant alterations in both hepatic and blood PC levels in diabetic versus control rats. <ref type="bibr" target="#b110">109</ref></s><s>egardless, the strong associations between the PCs and LPCs with multiple diabetes-related outcomes in our study are not surprising given the established link between PCs (the most abundant phospholipid), dyslipidemia and obesity-associated insulin resistance. <ref type="bibr" target="#b120">119</ref></s><s>search on the association between arsenic metabolism and PCs is limited.</s><s>An experimental study found a strong effect of arsenic (+3 oxidation state) methyltransferase (As3mt), the key enzyme for inorganic arsenic methylation, knockout on both plasma and urine PCs in mice. <ref type="bibr" target="#b121">120</ref></s><s>This is the first study to evaluate the association between arsenic metabolism and PCs in humans.</s><s>Our particularly strong (meeting Bonferroni correction criteria (p=0.0015))</s><s>correlations between LPC and all three arsenic metabolite percentages is intriguing.</s><s>LPC is formed by the hydrolysis of aaPCs, during which a fatty acid is freed. <ref type="bibr" target="#b52">52</ref></s><s>In turn, LPCs are hydrolyzed to choline. <ref type="bibr" target="#b122">121</ref></s><s>As choline assists in the remethylation of Hcys to methionine in the OCM pathway through conversion to betaine, we might expect LPCs to be associated with enhanced arsenic metabolism.</s><s>However, our results suggest the opposite and may reflect the fact that the PC/LPC pathway for choline synthesis, one of two choline synthesis pathways, consumes three molecules of SAM per molecule of choline. <ref type="bibr" target="#b97">96,</ref><ref type="bibr" target="#b123">122,</ref><ref type="bibr" target="#b124">123</ref> T</s><s>s is supported by the significant inverse correlation (−0.35) between SAM and LPC 18:2 in this study.</s></p><p><s>Together, our results provide evidence that OCM metabolites may have an instrumental role in the previously observed associations between arsenic metabolism and diabetes-related outcomes.</s><s>In our regression analyses, we show strong attenuations and loss of significance for associations between both DMA% and MMA% with HOMA2-IR and waist circumference after adjustment for OCM metabolites.</s><s>We propose 3 potential pathways for how these OCM metabolites may influence the observed relationships between arsenic metabolism and diabetes-related outcomes.</s><s>First, as represented in DAG 1 (Figure <ref type="figure">3</ref>), OCM metabolites may be acting as confounders.</s><s>All of the OCM metabolites were positively associated with HOMA2-IR and waist circumference were also positively associated with enhanced arsenic metabolism capacity.</s><s>Likewise, the metabolites negatively correlated with those two diabetes-related outcomes were also associated with reduced arsenic metabolism capacity.</s><s>Further, the previous paragraphs have summarized the consistency of these findings with other studies.</s><s>In this way, OCM metabolites could cause a spurious association between enhanced arsenic metabolism and higher HOMA2-IR and waist circumference.</s></p><p><s>Second, as represented in DAG 2 (Figure <ref type="figure">3</ref>), the associations seen between both OCM metabolites and arsenic metabolism with diabetes-related outcomes may be a result of reverse causality.</s><s>Despite multiple metabolomic studies showing an association between most of our metabolites of interest with incident diabetes, it is still possible diabetes converters were in early stages of disease progression, causing early metabolite alterations, which in turn affected arsenic metabolism.</s></p><p><s>Finally, as represented in DAG 3 (Figure <ref type="figure">3</ref>), OCM may still directly affect diabetes-related outcomes and arsenic metabolism (per DAG 1), however, in this scenario, part of the effect of OCM metabolites on HOMA2-IR and waist circumference is through its influence on arsenic metabolism.</s><s>The results of this study provide evidence that arsenic metabolism alone is not responsible for the associations reported between arsenic metabolism and diabetesrelated outcomes.</s><s>However, it is still possible arsenic metabolism has some effect on diabetes-related outcomes and is not simply confounded by OCM metabolites (DAG 1) or an outcome of insulin resistance (DAG 2); instead it is acting as a partial mediator in the association between OCM and diabetes outcomes.</s><s>Robust mechanistic evidence is lacking for this pathway, however, the trivalent forms of DMA (DMAIII) and MMA (MMAIII) have been shown to be potent inhibitors of insulin signal transduction in experimental models, 124, 125 providing some explanation for greater diabetes risk with higher DMA%, although we are not able to distinguish between DMAIII and DMAV.</s><s>Still it is unclear how this would lead to lower MMA% being inversely associated with diabetes outcomes, unless it was just an indirect association due to an increased risk with DMA%.</s><s>Another theory postulates that increased methylation reactions of methyl-consuming xenobiotics, such as arsenic, may lead to a depletion of the endogenous methyl pool and generation of reactive oxygen species, and in turn tissue injury. <ref type="bibr" target="#b127">126</ref></s><s>We feel this to be unlikely, as the methylation of As consumes a very small proportion of SAM (&lt; 4%). <ref type="bibr" target="#b128">127</ref></s><s>is study was limited by a small sample size and therefore conclusions should be interpreted with caution.</s><s>Further, due the small sample size, final models did not include other confounders for arsenic metabolism diabetes-related outcomes, such as age and sex.</s><s>Final models also did not account for family relatedness.</s><s>However, in sensitivity analyses adjusting for those factors resulted in similar findings.</s><s>Finally, availability of just a single urine and blood sample prevented prospective analyses, which are needed to confirm direction of associations as well as mediation analyses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">CONCLUSIONS</head><p><s>We found that several OCM-related metabolites were significantly and relatively strongly associated with both arsenic metabolism and diabetes-related outcomes.</s><s>LPC 18:2 had the strongest association with arsenic metabolism, a novel finding that warrants additional research.</s><s>In addition, glutamate, LPC 18:2 and PC ae 40:6 remained significantly associated with waist circumference after adjustment for both arsenic metabolism and all other metabolites, highlighting a potential role of these three metabolites in the development or physiological consequences of central adiposity.</s><s>Adjusting arsenic metabolism biomarkers for all OCM-related metabolites in models evaluating the association between arsenic metabolism and both HOMA2-IR and waist circumference resulted in significant attenuations and losses in statistical significance.</s><s>Our findings provide evidence that the OCM pathway may be -either directly or indirectly -influencing the previously reported relationship between arsenic metabolism and diabetes-related outcomes.</s><s>Further, this pathway may, in part, explain the contrasting associations seen between arsenic metabolism and diabetes-related outcomes versus arsenic metabolism and other arsenic-related health outcomes.</s><s>Abbreviations: OCM (one carbon metabolism) One carbon metabolism metabolites of interest (i.e., metabolites significantly correlated with both arsenic metabolism and a metabolic outcome) are highlighted in pink (a-f).</s><s>OCM facilitates the generation of SAM (a), the methyl donor for numerous substrates, which are essential to many biological processes including arsenic metabolism.</s><s>SAH (b) is a product of SAM-dependent methylation reactions, and is hydrolyzed to Hcys, which can be remethylated to form methionine and activated to regenerate SAM.</s><s>SAH is a potent inhibitor of most transmethylation reactions, including arsenic, through its binding with methyltransferases.</s><s>SAH is only removed from methyltransferases if Hcys is pulled forward for the remethylation of Hcys to form methionine or diverted to the transsulfuration pathway for glutathione synthesis.</s><s>Glutathione is a tripeptide consisting of cysteine (c), glutamate (d), and glycine and is critical to the body's antioxidant response (in its reduced form as GSH), including detoxification of heavy metals.</s><s>Choline can provide methyl groups for the remethylation of Hcys through conversion to betaine.</s><s>Choline is also used in the synthesis of phosphatidylcholine (PC) (e), an abundant phospholipid involved in maintenance of hepatic lipid metabolism.</s><s>PCs may also be synthesized through the methylation of phosphatidylethanolamine (PE) using SAM as the methyl donor.</s><s>aaPCs consist of glycerol linked to phosphocholine and two fatty acid residues, and removal of one fatty acid produces LPCs (f).</s><s>aePC's comprise an ether linkage to one alkyl chain and one polyunsaturated fatty acid.</s><s>Abbreviations: As (inorganic arsenic); DMA (dimethylarsinic acid); GSH (glutathione); LPCs (lysophosphatidilycholines); MMA (monomethylarsonic acid); PCs (phosphatidylcholines); SAH (s-adenosylhomocysteine); SAM (S-adenosylmethionine)  Abbreviations: RDA (recommended dietary allowance); ΣAs (sum of inorganic arsenic and its methylated metabolites); iAs (inorganic arsenic); MMA (monomethylarsonic acid);DMA (dimethylarsinic acid)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DMA</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Dimethylarsinic acid</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DAGs</head><p><s>a Excluding participants with missing data on variables in table b RDA for B 6 : Males (≤50 years=1.3</s><s>mg; &gt;50=1.7 mg); Females (14-18 years=1.2</s><s>mg; 19-50 years=1.3</s><s>mg; &gt;50 years=1.5 mg) c RDA for B 2 : Males (≥14 years =1.3 mg); Females (14-18 years=1.0</s><s>mg; &gt;18 years=1.1 mg)</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Correlation matrices between and within metabolite and biomarker groups.Transparent lines reflect correlations ≥ |15|.</s><s>Solid lines represent correlations with p-values ≤ 0.05.</s><s>Abbreviations: ∑As (sum of inorganic arsenic and its methylated metabolites); iAs (inorganic arsenic); DMA (dimethylarsinic acid); FPG (fasting plasma glucose); LPC (lysophosphatidylcholine); MMA (monomethylarsonic acid); OCM (one carbon metabolism); PC (phosphatidylcholine); SAH (S-Adenosylhomocysteine); SAM (S-Adenosylmethionine); WC (waist circumference)</s></p></div></figDesc><graphic coords="21,152.76,62.00,366.48,503.51" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 .Figure 3 .</head><label>23</label><figDesc><div><p><s>Figure 2. Spearman Correlations between arsenic metabolism biomarkers, diabetes-related outcomes, and metabolites of interest.∑As</s><s>and HOMA2-IR are log-transformed.</s><s>P-value &lt;0.05 for correlations ≥0.26; P-value &lt;0.01 for correlations ≥0.33; P-value &lt;0.001 for correlations ≥0.42.</s><s>Blue shading reflects negative correlations, red shading reflects positive correlations.</s><s>Darker shades of both colors reflect stronger correlations.</s><s>Abbreviations: Sum As (sum of inorganic arsenic and its methylated metabolites); DMA (dimethylarsinic acid); FPG (fasting plasma glucose); HOMA (homeostasis model assessment); iAs (inorganic arsenic); LPC (lysophosphatidylcholine); MMA (monomethylarsonic acid); PC (phosphatidylcholine); SAH (S-Adenosylhomocysteine); SAM (S-Adenosylmethionine); WC (waist circumference)</s></p></div></figDesc><graphic coords="22,107.04,62.00,457.92,457.20" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4. Study Metabolites in the One Carbon Metabolism Pathway.</s></p></div></figDesc><graphic coords="24,113.19,62.00,445.62,257.04" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>44 )Fasting</head><label>44</label><figDesc><div><p></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="23,189.12,62.00,293.76,287.76" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>Therefore, the true percentage of participants with inadequate folate intake is likely lower.</s><s>Evaluation of plasma folate (5-MTHF) confirmed no participants were folate deficient (5-MTHF ≤9 nmo/L) (data not shown).</s><s>Further, only seven participants had hyperhomocysteinemia (homocysteine &gt;11.4 μmol/L and 10.4 μmol/L for men and women, respectively) suggesting vitamin B12 status was also likely sufficient in this population as well (data not shown).</s></p></div></figDesc><table><row><cell>Median (IQR) plasma folate and homocysteine</cell></row><row><cell>levels were 51.3 (40.2, 63.9) and 7.53 (5.85, 8.98), respectively. Forty-two percent of</cell></row><row><cell>participants were never smokers, 22% were former smokers and 36% were current smokers.</cell></row><row><cell>A total of 14% of participants reported never drinking alcohol, 25% reported former</cell></row><row><cell>drinking and 61% reported current drinking. Median (IQR) for ∑As, iAs%, MMA% and</cell></row><row><cell>DMA% were 3.66 (2.64, 8.27) μg/g creatinine, 10.7 (7.29, 16.4)%, 15.3 (11.3, 19.9)% and</cell></row><row><cell>72.9 (65.9, 78.8)%, respectively. Median (IQR) for diabetes-related outcomes were 1.44</cell></row><row><cell>(1.06, 2.62) for HOMA2-IR, 93.0 (89.0, 101.5) mg/dL for FPG and 105.0 (91.5, 117.5) cm</cell></row><row><cell>for waist circumference. Participant characteristics were similar in the pilot sample</cell></row><row><cell>compared to the full cohort.</cell></row></table><note><p><s>(63%) and did not take folate supplements (75%), although RDAs used to categorize inadequate folate intake are based on dietary folate equivalents (DFEs), which incorporate different forms of folate (e.g., folic acid) and could not be measured in this dataset.Eight metabolites were identified as metabolites of interest due to correlations with both an arsenic metabolism variable (iAs%, MMA% or DMA%) and a metabolic outcome (HOMA2-IR, FPG, waist circumference) that reached statistical significance p&lt;0.05.These metabolites included SAM, SAH, cysteine, glutamate, LPC 18.2, PC ae 34:3, PC ae 40:6 and PC aa 38:3.Spearman correlations between arsenic metabolism variables, diabetesrelated outcomes and metabolites of interest are displayed in Figure2.</s><s>SAM, SAH, cysteine, glutamate and PC aa 38:3 were positively correlated with adverse diabetes-related outcomes and DMA%, and negatively correlated with MMA% and iAs%.</s><s>LPC 18:2 and acyl-alkyl PCs (PC ae 34:3 and PC ae 40:6) were negatively correlated with adverse diabetes-related outcomes and DMA% and positively correlated with MMA% and iAs%.</s><s>DMA% had a significant positive correlation with HOMA2-IR (0.34) and waist circumference (0.36).</s><s>MMA% was significantly negatively correlated with HOMA2-IR, FPG and waist circumference.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Participant Characteristics, Pilot versus Full Strong Heart Family Study Cohort</s></p></div></figDesc><table><row><cell></cell><cell>Pilot (N=59)</cell><cell>Full Cohort (N=1577) a</cell></row><row><cell>Age (years), median (IQR)</cell><cell>35.3 (26.4, 46.3)</cell><cell>35.3 (23.6, 46.3)</cell></row><row><cell>Sex</cell><cell></cell><cell></cell></row><row><cell>Male, n (%)</cell><cell>28 (47.5)</cell><cell>654 (41.6)</cell></row><row><cell>Female, n (%)</cell><cell>31 (52.5)</cell><cell>923 (58.4)</cell></row><row><cell>Smoking</cell><cell></cell><cell></cell></row><row><cell>Never, n (%)</cell><cell>25 (42.4)</cell><cell>647 (41.1)</cell></row><row><cell>Ever, n (%)</cell><cell>13 (22.0)</cell><cell>325 (20.6)</cell></row><row><cell>Current, n (%)</cell><cell>21 (35.6)</cell><cell>604 (38.3)</cell></row><row><cell>Alcohol Intake</cell><cell></cell><cell></cell></row><row><cell>Never, n (%)</cell><cell>8 (13.6)</cell><cell>173 (11.0)</cell></row><row><cell>Ever, n (%)</cell><cell>15 (25.4)</cell><cell>406 (25.8)</cell></row><row><cell>Current, n (%)</cell><cell>36 (61.0)</cell><cell>997 (63.3)</cell></row><row><cell>BMI (kg/m 2 )</cell><cell>31.6 (25.9, 38.0)</cell><cell>29.8 (25.5, 35.0)</cell></row><row><cell>Vitamin B 6 intake (mg)</cell><cell>1.60 (1.05, 2.65)</cell><cell>1.70 (1.10, 2.60)</cell></row><row><cell>&lt;RDA b , n (%)</cell><cell>21 (35.6)</cell><cell>545 (34.6)</cell></row><row><cell>≥RDA b , n (%)</cell><cell>38 (64.4)</cell><cell>1032 (65.4)</cell></row><row><cell>Vitamin B 2 intake (mg)</cell><cell>1.60 (1.00, 2.30)</cell><cell>1.70 (1.10, 2.70)</cell></row><row><cell>&lt;RDA c , n (%)</cell><cell>19 (32.2)</cell><cell>358 (22.7)</cell></row><row><cell>≥RDA c , n (%)</cell><cell>40 (67.8)</cell><cell>1219 (77.3)</cell></row><row><cell>Folate intake (μg)</cell><cell>348 (226, 518)</cell><cell>360 (234, 559)</cell></row><row><cell>&lt;RDA d , n (%)</cell><cell>37 (62.7)</cell><cell>890 (56.4)</cell></row><row><cell>≥RDA d , n (%)</cell><cell>22 (37.3)</cell><cell>687 (43.6)</cell></row><row><cell>Plasma Folate (nmol/L)</cell><cell>51.3 (40.2, 63.9)</cell><cell>---</cell></row><row><cell>Plasma Homocysteine (μmol/L)</cell><cell>7.53 (5.85, 8.98)</cell><cell>---</cell></row><row><cell>ΣAs (μg/g)</cell><cell>3.66 (2.64, 8.27)</cell><cell>4.59 (3.02, 7.49)</cell></row><row><cell>iAs%</cell><cell>10.7 (7.29, 16.4)</cell><cell>10.0 (6.94, 14.1)</cell></row><row><cell>MMA%</cell><cell>15.3 (11.3, 19.9)</cell><cell>14.5 (11.1, 18.2)</cell></row><row><cell>DMA%</cell><cell>72.9 (65.9, 78.8)</cell><cell>74.6 (67.8, 80.8)</cell></row><row><cell>HOMA2-IR</cell><cell>1.44 (1.06, 2.62)</cell><cell>1.44 (0.97, 1.</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Environ Res. Author manuscript; available in PMC 2020 January 01.</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">d RDA for folate: Males and Females ≥14 years=400 μg Environ Res. Author manuscript; available in PMC 2020 January 01.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>FUNDING SOURCES</head><p><s>This work was supported by grants 1F31ES027796-01, 5T32ES007141-33, R01ES025216, 5P30ES009089 and P42ES010349 from NIEHS and grants R01-HL090863, R01-HL109315, R01HL109301, R01HL109284, R01HL109282, R01HL109319, U01-HL41642, U01-HL41652, U01-HL41654, U01-HL65520, U01-HL65521 from NHLBI.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary Material</head><p><s>Refer to Web version on PubMed Central for supplementary material.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Abbreviations:</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>5-MTHF</head><p><s>5-methyltetrahydrofolate ∑As Arsenic exposure measured as urine arsenic levels</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HIGHLIGHTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>•</head><p><s>One carbon metabolism, arsenic and diabetes appear to be interconnected   <ref type="figure">-----------------------------------------</ref>  <ref type="figure">-----------------------------------------</ref></s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Arsenic exposure and cardiovascular disease: an updated systematic review</title>
		<author>
			<persName><forename type="first">K</forename><surname>Moon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Guallar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Navas-Acien A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Atheroscler Rep</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="542" to="555" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22968315</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Naujokas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Health Perspect</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="295" to="302" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23458756</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Arsenic exposure, arsenic metabolism, and incident diabetes in the strong heart study</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Kuo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="620" to="627" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25583752</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">The Effects of Arsenic Exposure on Neurological and Cognitive Dysfunction in Human and Rodent Studies: A Review</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Tyler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Allan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Environ Health Rep</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="132" to="147" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24860722</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Arsenic Exposure and Subclinical Endpoints of Cardiovascular Diseases</title>
		<author>
			<persName><forename type="first">F</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Molinaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Chen</forename><forename type="middle">Y</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Environ Health Rep</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="148" to="162" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 25013752</note>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title level="m" type="main">Arsenic in drinking water</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Council</surname></persName>
		</author>
		<editor>update, Council NR</editor>
		<imprint>
			<date type="published" when="2001">2001. 2001</date>
			<pubPlace>Washington DC</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The association between total urinary arsenic concentration and renal dysfunction in a community-based population from central Taiwan</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chemosphere</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="17" to="24" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21458841</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Influence of cobalamin on arsenic metabolism in Bangladesh</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Hall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Health Perspect</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1724" to="1729" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 20049124</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Nutritional manipulation of one-carbon metabolism: effects on arsenic methylation and toxicity</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Gamble</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Toxicol</title>
		<imprint>
			<biblScope unit="page">595307</biblScope>
			<date type="published" when="2012">2012 2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22523489</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity</title>
		<author>
			<persName><forename type="first">M</forename><surname>Vahter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Toxicol Lett</title>
		<imprint>
			<biblScope unit="page" from="209" to="217" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Genetic variations associated with interindividual sensitivity in the response to arsenic exposure</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Marcos</forename><forename type="middle">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacogenomics</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1113" to="1132" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18681785</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The temporal stability of arsenic concentrations in well water in western Nevada</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Steinmaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Res</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="164" to="168" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 16194666</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Changes in urinary arsenic methylation profiles in a 15-year interval after cessation of arsenic ingestion in southwest Taiwan</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Health Perspect</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1860" to="1866" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 20049204</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ahsan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1270" to="1278" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17548696</note>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title level="m" type="main">Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
		<imprint>
			<pubPlace>Bangladesh</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Toxicol Appl Pharmacol</title>
		<imprint>
			<biblScope unit="volume">239</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="184" to="192" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19371619</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Association of AS3MT polymorphisms and the risk of premalignant arsenic skin lesions</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">L</forename><surname>Valenzuela</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Toxicol Appl Pharmacol</title>
		<imprint>
			<biblScope unit="volume">239</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="200" to="207" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19538983</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States</title>
		<author>
			<persName><forename type="first">C</forename><surname>Steinmaus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Occup Environ Med</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="478" to="488" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 16688004</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Exposure, metabolism, and health effects of arsenic in residents from arseniccontaminated groundwater areas of Vietnam and Cambodia: a review</title>
		<author>
			<persName><forename type="first">T</forename><surname>Agusa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Environ Health</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="193" to="220" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 21038756</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Arsenic methylation and skin cancer risk in southwestern Taiwan</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Occup Environ Med</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="241" to="248" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 12661181</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Arsenic methylation capacity and skin cancer</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Yu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1259" to="1262" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>PubMed: 11097236</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Causes Control</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="829" to="839" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18351295</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba</title>
		<author>
			<persName><forename type="first">C</forename><surname>Steinmaus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Argentina. Toxicol Appl Pharmacol</title>
		<imprint>
			<biblScope unit="volume">247</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="138" to="145" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20600216</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Toxicol Appl Pharmacol</title>
		<imprint>
			<biblScope unit="volume">218</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="135" to="142" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17173945</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Total Environ</title>
		<imprint>
			<biblScope unit="volume">407</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2608" to="2614" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19187952</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Health Perspect</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="832" to="838" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23665672</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Differences in urinary arsenic metabolites between diabetic and non-diabetic subjects in Bangladesh</title>
		<author>
			<persName><forename type="first">S</forename><surname>Nizam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Environ Res Public Health</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1006" to="1019" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23481591</note>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title level="m" type="main">Chronic Exposure to Arsenic and Markers of Cardiometabolic Risk: A Cross-Sectional Study in Chihuahua, Mexico. Environ Health Perspect</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Mendez</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2016">2016</date>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="104" to="111" />
		</imprint>
	</monogr>
	<note>PubMed: 26068977</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapan and Lagunera regions in Mexico</title>
		<author>
			<persName><forename type="first">Del</forename><surname>Razo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Health</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">73</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21864395</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Measures of adiposity and body fat distribution in relation to serum folate levels in postmenopausal women in a feeding study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mahabir</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="644" to="650" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 17457338</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Dietary Intakes of Folic Acid and Methionine in Early Childhood Are Associated with Body Composition at School Age</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Braun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2123" to="2129" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 26203097</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Obesity is associated with increased red blood cell folate despite lower dietary intakes and serum concentrations</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Bird</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="79" to="86" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25527662</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Dietary nutrient intake and metabolic syndrome risk in Chinese adults: a case-control study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nutr J</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">106</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23898830</note>
</biblStruct>

<biblStruct xml:id="b33">
	<monogr>
		<title level="m" type="main">Link of dietary patterns with metabolic syndrome: analysis of the National Health and Nutrition Examination Survey. Nutr Diabetes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mazidi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pennathur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Afshinnia</forename><forename type="middle">F</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2017">2017</date>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e255</biblScope>
		</imprint>
	</monogr>
	<note>PubMed: 28319105</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Choline and its metabolites are differently associated with cardiometabolic risk factors, history of cardiovascular disease, and MRI-documented cerebrovascular disease in older adults</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Roe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1283" to="1290" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>PubMed: 28356272</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Low serum vitamin B-12 and folate concentrations and low thiamin and riboflavin intakes are inversely associated with greater adiposity in Mexican American children</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">R</forename><surname>Gunanti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2027" to="2033" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 25411037</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Arsenic metabolism and one-carbon metabolism at low-moderate arsenic exposure: Evidence from the Strong Heart Study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Spratlen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Food Chem Toxicol</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="387" to="397" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>PubMed: 28479390</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Consumption of folate-related nutrients and metabolism of arsenic in Bangladesh</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Heck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1367" to="1374" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17490975</note>
</biblStruct>

<biblStruct xml:id="b38">
	<monogr>
		<title level="m" type="main">Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environ Health Perspect</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hall</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2007">2007</date>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="1503" to="1509" />
		</imprint>
	</monogr>
	<note>PubMed: 17938743</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Folate and arsenic metabolism: a double-blind, placebo-controlled folic acidsupplementation trial in Bangladesh</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Gamble</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1093" to="1101" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>PubMed: 17093162</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Folate and cobalamin deficiencies and hyperhomocysteinemia in Bangladesh</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Gamble</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1372" to="1377" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 15941889</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Gamble</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Health Perspect</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1683" to="1688" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 16330347</note>
</biblStruct>

<biblStruct xml:id="b42">
	<monogr>
		<title level="m" type="main">Folic Acid and Creatine as Therapeutic Approaches to Lower Blood Arsenic: A Randomized Controlled Trial. Environ Health Perspect</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Peters</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="1294" to="1301" />
		</imprint>
	</monogr>
	<note>PubMed: 25978852</note>
</biblStruct>

<biblStruct xml:id="b43">
	<monogr>
		<title level="m" type="main">Homocysteine in Health and Disease</title>
		<author>
			<persName><forename type="first">Ralph</forename><surname>Carmel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dwj</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2001">2001</date>
			<publisher>Cambridge University Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Novel metabolic markers for the risk of diabetes development in American Indians</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zhao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="220" to="227" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25468946</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Rhee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1402" to="1411" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21403394</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Metabolite profiles and the risk of developing diabetes</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="448" to="453" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21423183</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study</title>
		<author>
			<persName><forename type="first">D</forename><surname>Drogan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="487" to="497" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25524438</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach</title>
		<author>
			<persName><forename type="first">A</forename><surname>Floegel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="639" to="648" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23043162</note>
</biblStruct>

<biblStruct xml:id="b49">
	<monogr>
		<title level="m" type="main">Navas-Acien A, Association of low-moderate arsenic exposure and arsenic metabolism with incident diabetes and insulin resistance in the Strong Heart Family Study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Grau-Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Gribble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Balakrishnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Spratlen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Vaidya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Francesconi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Goessler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Guallar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Silbergeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Umans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Best</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">T</forename><surname>Howard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">V</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2017">2017</date>
			<publisher>Environmental Health Perspectives</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Body composition and arsenic metabolism: a cross-sectional analysis in the Strong Heart Study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Gribble</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Health</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">107</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 24321145</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Navas-Acien A, The Association of Arsenic Exposure and Arsenic Metabolism with the Metabolic Syndrome and its Individual Components: Prospective Evidence from the Strong Heart Family Study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Spratlen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G.-P</forename><forename type="middle">M</forename><surname>Best</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Yracheta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lazo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vaidya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Balakrishnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gamble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Francesconi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Goessler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Umans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Howard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">V</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">American Journal of Epidemiology</title>
		<imprint>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Novel biomarkers for pre-diabetes identified by metabolomics</title>
		<author>
			<persName><forename type="first">R</forename><surname>Wang-Sattler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Syst Biol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">615</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 23010998</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">2-Aminoadipic acid is a biomarker for diabetes risk</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="4309" to="4317" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 24091325</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention Program</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Walford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1424" to="1433" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 26861782</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach</title>
		<author>
			<persName><forename type="first">C</forename><surname>Menni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="4270" to="4276" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23884885</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Early metabolic markers identify potential targets for the prevention of type 2 diabetes</title>
		<author>
			<persName><forename type="first">G</forename><surname>Peddinti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance</title>
		<author>
			<persName><forename type="first">E</forename><surname>Ferrannini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1730" to="1737" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23160532</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>North</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="303" to="314" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 12578801</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Correct homeostasis model assessment (HOMA) evaluation uses the computer program</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Hermans</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2191" to="2192" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note>PubMed: 9839117</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Use and abuse of HOMA modeling</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Matthews</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1487" to="1495" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note>PubMed: 15161807</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Matthews</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="412" to="419" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
	<note>PubMed: 3899825</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Quantitation of S-Adenosylmethionine and S-Adenosylhomocysteine in Plasma Using Liquid Chromatography-Electrospray Tandem Mass Spectrometry</title>
		<author>
			<persName><forename type="first">E</forename><surname>Arning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bottiglieri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods Mol Biol</title>
		<imprint>
			<biblScope unit="page" from="255" to="262" />
			<date>2016 1378</date>
		</imprint>
	</monogr>
	<note>PubMed: 26602137</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Quantitation of 5-Methyltetrahydrofolate in Cerebrospinal Fluid Using Liquid Chromatography-Electrospray Tandem Mass Spectrometry</title>
		<author>
			<persName><forename type="first">E</forename><surname>Arning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bottiglieri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods Mol Biol</title>
		<imprint>
			<biblScope unit="page" from="175" to="182" />
			<date>2016 1378</date>
		</imprint>
	</monogr>
	<note>PubMed: 26602129</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Butler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1884" to="1893" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23897582</note>
</biblStruct>

<biblStruct xml:id="b65">
	<monogr>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Yurgalevitch</surname></persName>
		</author>
		<title level="m">Physical activity and lipids and lipoproteins in American Indians ages</title>
				<imprint>
			<biblScope unit="page">45</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Med Sci Sports Exerc</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="543" to="549" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note>PubMed: 9565936</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Associations of processed meat and unprocessed red meat intake with incident diabetes: the Strong Heart Family Study</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Fretts</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="752" to="758" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22277554</note>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Arsenic exposure, diabetes prevalence, and diabetes control in the Strong Heart Study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Gribble</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="865" to="874" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 23097256</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Methylation study of a population environmentally exposed to arsenic in drinking water</title>
		<author>
			<persName><forename type="first">C</forename><surname>Hopenhayn-Rich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Health Perspect</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="620" to="628" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note>PubMed: 8793350</note>
</biblStruct>

<biblStruct xml:id="b70">
	<monogr>
		<title level="m" type="main">Riboflavin Fact Sheet for Health Professionals</title>
		<editor>N.I.o.H.O.o.D. Supplements</editor>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
		<respStmt>
			<orgName>NIH</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<monogr>
		<title level="m" type="main">Folate Dietary Supplement Fact Sheet</title>
		<editor>N.I.o.H.O.o.D. Supplements</editor>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
		<respStmt>
			<orgName>NIH</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Arsenic exposure and cancer mortality in a US-based prospective cohort: the strong heart study</title>
		<author>
			<persName><forename type="first">E</forename><surname>Garcia-Esquinas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1944" to="1953" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23800676</note>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Association between exposure to low to moderate arsenic levels and incident cardiovascular disease. A prospective cohort study</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Moon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="649" to="659" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 24061511</note>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Maternal arsenic exposure and birth outcomes: a comprehensive review of the epidemiologic literature focused on drinking water</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Bloom</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Hyg Environ Health</title>
		<imprint>
			<biblScope unit="volume">217</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="709" to="719" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24713268</note>
</biblStruct>

<biblStruct xml:id="b75">
	<monogr>
		<title level="m" type="main">Association of arsenic with adverse pregnancy outcomes/infant mortality: a systematic review and meta-analysis. Environ Health Perspect</title>
		<author>
			<persName><forename type="first">R</forename><surname>Quansah</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="412" to="421" />
		</imprint>
	</monogr>
	<note>PubMed: 25626053</note>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Arsenic methylation and skin lesions in migrant and native adult women with chronic exposure to arsenic from drinking groundwater</title>
		<author>
			<persName><forename type="first">B</forename><surname>Wei</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Geochem Health</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="89" to="98" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>PubMed: 26935566</note>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Associations of arsenic metabolites, methylation capacity, and skin lesions caused by chronic exposure to high arsenic in tube well water</title>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Toxicol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="28" to="36" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>PubMed: 26494561</note>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">The Association of Arsenic Metabolism with Cancer, Cardiovascular Disease, and Diabetes: A Systematic Review of the Epidemiological Evidence</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Kuo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Health Perspect</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">87001</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>PubMed: 28796632</note>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">F</forename><surname>Challenger</surname></persName>
		</author>
		<author>
			<persName><surname>Biological Methylation</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Enzymol Relat Subj Biochem</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="429" to="491" />
			<date type="published" when="1951">1951</date>
		</imprint>
	</monogr>
	<note>PubMed: 14885024</note>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Maull</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Health Perspect</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1658" to="1670" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22889723</note>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Tseng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Health Perspect</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="847" to="851" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>PubMed: 11017889</note>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Diabetes mellitus associated with arsenic exposure in Bangladesh</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rahman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="198" to="203" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note>PubMed: 9676702</note>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Ingested inorganic arsenic and prevalence of diabetes mellitus</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Lai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="484" to="492" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note>PubMed: 8154472</note>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Health Perspect</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="155" to="159" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 12573898</note>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Arsenic exposure and incidence of type 2 diabetes in Southwestern American Indians</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="962" to="969" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23504692</note>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">A case-cohort study examining lifetime exposure to inorganic arsenic in drinking water and diabetes mellitus</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>James</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Res</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="33" to="38" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23507312</note>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Arsenic exposure and prevalence of type 2 diabetes in US adults</title>
		<author>
			<persName><forename type="first">A</forename><surname>Navas-Acien</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">300</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="814" to="822" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18714061</note>
</biblStruct>

<biblStruct xml:id="b88">
	<monogr>
		<title level="m" type="main">Arsenic exposure and type 2 diabetes: results from the 2007-2009 Canadian Health Measures Survey. Health Promot Chronic Dis Prev Can</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Feseke</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="63" to="72" />
		</imprint>
	</monogr>
	<note>PubMed: 26083521</note>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Association between urinary arsenic and diabetes mellitus in the Korean general population according to KNHANES</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Total Environ</title>
		<imprint>
			<biblScope unit="volume">409</biblScope>
			<biblScope unit="page" from="4054" to="4062" />
			<date type="published" when="2008">2008. 2011. 19</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Low-level population exposure to inorganic arsenic in the United States and diabetes mellitus: a reanalysis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Steinmaus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Epidemiology</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="807" to="815" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19652600</note>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">A preliminary assessment of low level arsenic exposure and diabetes mellitus in Cyprus</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Makris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Public Health</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">334</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22569201</note>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Health Perspect</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1299" to="1305" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20813654</note>
</biblStruct>

<biblStruct xml:id="b93">
	<monogr>
		<title level="m" type="main">Navas-Acien Ana, The association of low-moderate arsenic exposure and arsenic metabolism with incident diabetes and insulin resistance in the Strong Heart Family Study</title>
		<author>
			<persName><forename type="first">C.-C</forename><forename type="middle">K</forename><surname>Grau-Perez Maria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gribble</forename><surname>Matthew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Balakrishnan Poojitha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vaidya</forename><surname>Dhananjay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Francesconi</forename><surname>Kevin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Goessler</forename><surname>Walter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Guallar</forename><surname>Eliseo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Silbergeld</forename><surname>Ellen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Umans</forename><surname>Jason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Best Lyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Lee</forename><surname>Elisa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Howard</forename><surname>Barbara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Cole</forename><surname>Shelley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Arsenic methylation, GSTO1 polymorphisms, and metabolic syndrome in an arseniasis endemic area of southwestern Taiwan</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chemosphere</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="432" to="438" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22440634</note>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">A mathematical model of glutathione metabolism</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Reed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Theor Biol Med Model</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">8</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18442411</note>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Novel insights on interactions between folate and lipid metabolism</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Da Silva</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biofactors</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="277" to="283" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24353111</note>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Phosphatidylcholine and choline homeostasis</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Vance</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Lipid Res</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1187" to="1194" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18204095</note>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Elevated venous glutamate levels in (pre)catabolic conditions result at least partly from a decreased glutamate transport activity</title>
		<author>
			<persName><forename type="first">V</forename><surname>Hack</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Med (Berl)</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="337" to="343" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note>PubMed: 8862515</note>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">The potential role of glutamate in the current diabetes epidemic</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Davalli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Perego</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Folli</forename><surname>Fb</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Diabetol</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="167" to="183" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22218826</note>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Metabolite profiling identifies pathways associated with metabolic risk in humans</title>
		<author>
			<persName><forename type="first">S</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="2222" to="2231" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22496159</note>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Newgard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Metab</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="311" to="326" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19356713</note>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Bao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Proteome Res</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1623" to="1630" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19714868</note>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Palmer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="E463" to="468" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25423564</note>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Haley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Metab Brain Dis</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="397" to="405" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 21063759</note>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">The glial glutamate transporter 1 (GLT1) is expressed by pancreatic betacells and prevents glutamate-induced beta-cell death</title>
		<author>
			<persName><forename type="first">Di</forename><surname>Cairano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">286</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="14007" to="14018" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21335552</note>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Glutamate: a truly functional amino acid</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Brosnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Brosnan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Amino Acids</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="413" to="418" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 22526238</note>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc-as a neuroprotective drug target</title>
		<author>
			<persName><forename type="first">P</forename><surname>Albrecht</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CNS Neurol Disord Drug Targets</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="373" to="382" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20053169</note>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Effects of insulin and glucose on cellular metabolic fluxes in homocysteine transsulfuration, remethylation, S-adenosylmethionine synthesis, and global deoxyribonucleic acid methylation</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Chiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1017" to="1025" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19088160</note>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Epigenetics in adipose tissue, obesity, weight loss, and diabetes</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Martinez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Nutr</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="71" to="81" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24425725</note>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">Homocysteine metabolism in ZDF (type 2) diabetic rats</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Wijekoon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="3245" to="3251" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>PubMed: 16249451</note>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Folate and cobalamin modify associations between S-adenosylmethionine and methylated arsenic metabolites in arsenic-exposed Bangladeshi adults</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Howe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="690" to="697" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24598884</note>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Folate, Cobalamin, Cysteine, Homocysteine, and Arsenic Metabolism among Children in Bangladesh</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Hall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Health Perspect</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="825" to="831" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19479028</note>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">S-adenosyl-L-methionine is able to reverse micronucleus formation induced by sodium arsenite and other cytoskeleton disrupting agents in cultured human cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ramirez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mutat Res</title>
		<imprint>
			<biblScope unit="volume">528</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="61" to="74" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>PubMed: 12873724</note>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">S-adenosyl-L-methionine counteracts mitotic disturbances and cytostatic effects induced by sodium arsenite in HeLa cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ramirez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mutat Res</title>
		<imprint>
			<biblScope unit="volume">637</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="152" to="160" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 17888458</note>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">Neonatal Metabolomic Profiles Related to Prenatal Arsenic Exposure</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Laine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Environ Sci Technol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="625" to="633" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>PubMed: 27997141</note>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">Mathematical modeling of the effects of glutathione on arsenic methylation</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Lawley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Theor Biol Med Model</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">20</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24885596</note>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Metabolomics in diabetes, a review</title>
		<author>
			<persName><forename type="first">R</forename><surname>Pallares-Mendez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Med</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="89" to="102" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 26883715</note>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">Plasma lipid profiling in a large population-based cohort</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Weir</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Lipid Res</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2898" to="2908" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23868910</note>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">Cardiovascular Risk Factors Associated With Blood Metabolite Concentrations and Their Alterations During a 4-Year Period in a Population-Based Cohort</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Lacruz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Cardiovasc Genet</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="487" to="494" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 27784734</note>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">Sphingolipids and phospholipids in insulin resistance and related metabolic disorders</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Meikle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Summers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Endocrinol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="79" to="91" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>PubMed: 27767036</note>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Knockout of arsenic (+3 oxidation state) methyltransferase results in sex-dependent changes in phosphatidylcholine metabolism in mice</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Douillet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Styblo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Toxicol</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="3125" to="3128" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 27591999</note>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Metabolomic study in plasma, liver and kidney of mice exposed to inorganic arsenic based on mass spectrometry</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Garcia-Sevillano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anal Bioanal Chem</title>
		<imprint>
			<biblScope unit="volume">406</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1455" to="1469" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24448970</note>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main">Supplementation with Folic Acid, but Not Creatine, Increases Plasma Betaine, Decreases Plasma Dimethylglycine, and Prevents a Decrease in Plasma Choline in Arsenic-Exposed Bangladeshi Adults</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Hall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1062" to="1067" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 27052531</note>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">Choline: an essential nutrient for public health</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Zeisel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Da Costa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nutr Rev</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="615" to="623" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19906248</note>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Walton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Toxicol Appl Pharmacol</title>
		<imprint>
			<biblScope unit="volume">198</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="424" to="433" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note>PubMed: 15276423</note>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">Methylated trivalent arsenicals are potent inhibitors of glucose stimulated insulin secretion by murine pancreatic islets</title>
		<author>
			<persName><forename type="first">C</forename><surname>Douillet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Toxicol Appl Pharmacol</title>
		<imprint>
			<biblScope unit="volume">267</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="11" to="15" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23261974</note>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">Dietary methyl-consuming compounds and metabolic syndrome</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertens Res</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1239" to="1245" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21814217</note>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">Relationship of creatinine and nutrition with arsenic metabolism</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Gamble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Hall</surname></persName>
		</author>
		<idno>DMA% 3.66 (0.95, 6.38) −1.16 (−3.99</idno>
	</analytic>
	<monogr>
		<title level="j">Environ Health Perspect</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="A145" to="146" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>DMA% 0.75 (−0.49, 1.99) 0.14 (−1.56, 1.</note>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Abbreviations: DMA (dimethylarsinic acid</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b130">
	<monogr>
		<title level="m" type="main">FPG (fasting plasma glucose)</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<monogr>
		<title/>
		<author>
			<persName><surname>Lpc (lysophosphatidylcholine</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">MMA (monomethylarsonic acid</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">PC</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<monogr>
		<title/>
		<author>
			<persName><surname>Sah (s-Adenosylhomocysteine</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b135">
	<monogr>
		<title level="m" type="main">2: adjusted for the seven OCM-related metabolites (SAM, SAH, cysteine, glutamate</title>
		<author>
			<persName><surname>Sam (s-Adenosylmethionine</surname></persName>
		</author>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page">3</biblScope>
		</imprint>
	</monogr>
	<note>LPC 18:2, PC ae 40:6, PC ae 34:3, PC aa</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
